Neurons and Glia Spinal Motor Neurons Layer V Glutamatergic Neurons Midbrain Dopaminergic Neurons Cortical GABAergic Neurons Cortical Glutamatergic Neurons Microglia Mixed Cortical Neurons Medium Spiny Neurons Cortical Astrocytes Spinal Astrocytes
BrainXell的任务是将最相关的神经细胞 2015岁的苏春张博士与威斯康星大学麦迪逊分校的产品发现计划(D2P)合作成立,并在大学研究园的一个新设施中运作。该公司基于将人类干细胞(包括诱导多能干细胞)定向分化为高度富集的神经元亚类的专有技术。BrainXel提供一系列高纯度、iPSC衍生的人类神经元,用于研发,重点是药物发现。从运动神经元到皮质亚型,我们可以为疾病或正常药物筛选提供特定的模型。我们致力于提供优质的产品,无论是从我们的现成的神经元,以及任何定制服务项目。 BrainXel还致力于通过与制药和医疗行业的合作,开发针对神经损伤和疾病的干细胞疗法。BrainXel的目标是使我们的大脑健康。 BrainXell's mission is to bring the most relevant neuronal cell BrainXell was founded in 2015 by Prof. Su-Chun Zhang in conjunction with the Discovery to Product (D2P) program of University of Wisconsin- Madison and operates out of a new facility in University Research Park. The company is based on the proprietary technology of directed differentiation of human stem cells (including induced pluripotent stem cells) to highly enriched subclasses of neurons. BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery. From motor neurons to cortical sub-types, we can provide specific models for both disease or normal drug screening. We are dedicated to delivering the highest quality products from both our off-the-shelf neurons as well as any custom service projects. BrainXell also aims to develop stem cell therapy for neurological injuries and diseases through collaboration with pharmaceutical and healthcare industry. BrainXell’s goal is to make our brain healthy and well.